These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10308109)

  • 1. Official written patient drug-use information.
    Heller WM
    Drug Inf J; 1978; 12(1):59-62. PubMed ID: 10308109
    [No Abstract]   [Full Text] [Related]  

  • 2. The new USP-NF: drug standards and patient information.
    Heller WM
    Hosp Formul; 1980 Jan; 15(1):21-4. PubMed ID: 10244954
    [No Abstract]   [Full Text] [Related]  

  • 3. Proposed legislation--its impact on drug information processing.
    Cleveland CB; Adams J
    Drug Inf J; 1978; 12(3):181-4. PubMed ID: 10239117
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug marketing: nonfederal regulation.
    Skinner WJ
    Hosp Formul; 1978 Nov; 13(11):911-2, 915-6, 918. PubMed ID: 10239345
    [No Abstract]   [Full Text] [Related]  

  • 5. Doctor, what should pharmacists tell your patients about the drugs you prescribe?
    Valentino JG
    Hosp Formul; 1975 Jun; 10(6):255-7. PubMed ID: 10237840
    [No Abstract]   [Full Text] [Related]  

  • 6. Unusual sources of drug information required and utilized by the USP.
    Griffiths MC
    Drug Inf J; 1975; 9(2-3):73-5. PubMed ID: 10236980
    [No Abstract]   [Full Text] [Related]  

  • 7. Patient drug information--pharmacy overview.
    Romano JA; Rosman A
    Drug Inf J; 1977; 11(4):187-9. PubMed ID: 10307443
    [No Abstract]   [Full Text] [Related]  

  • 8. Written patient information: USPC's approach.
    Johnson K
    Am Pharm; 1981 Jul; NS21(7):50, 56. PubMed ID: 7270413
    [No Abstract]   [Full Text] [Related]  

  • 9. Physicians main source for drug information.
    AORN J; 1979 Oct; 30(4):812. PubMed ID: 258995
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse drug reactions.
    Shuttleworth A
    Nurs Times; 2006 Jul 25-31; 102(30):58. PubMed ID: 16903313
    [No Abstract]   [Full Text] [Related]  

  • 11. The medicolegal significance of the package insert.
    Hirsh HL
    Med Trial Tech Q; 1976; 23(2):143-50. PubMed ID: 1004155
    [No Abstract]   [Full Text] [Related]  

  • 12. Government and drug information--the FDA.
    Groth PE
    Drug Inf J; 1978; 12(1):33-6. PubMed ID: 10308103
    [No Abstract]   [Full Text] [Related]  

  • 13. [Unclear on dose adjustment in renal impairment].
    Asker-Hagelberg C; Rydberg D; Hentschke M; Holm L; Rosenborg S; Elinder CG
    Lakartidningen; 2013 May 22-28; 110(21):1030-2. PubMed ID: 23805768
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient drug information from the health professionals.
    Heller WM
    Drug Inf J; 1982; 16(3):112-4. PubMed ID: 10259422
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug information resources for treatment of acute drug overdose.
    Comstock EG
    Drug Inf J; 1975; 9(2-3):81-8. PubMed ID: 10236983
    [No Abstract]   [Full Text] [Related]  

  • 16. [Research in the field of scientific pharmaceutical information].
    Parnovskiĭ BL
    Farm Zh; 1978; (1):40-6. PubMed ID: 344059
    [No Abstract]   [Full Text] [Related]  

  • 17. Rules set for dissemination of off-label-use information.
    Miller JL
    Am J Health Syst Pharm; 1999 Feb; 56(3):204. PubMed ID: 10030500
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost present--cost future.
    Thomson A
    Drug Inf J; 1977; 11(4):197-202. PubMed ID: 10307447
    [No Abstract]   [Full Text] [Related]  

  • 19. Incorrect or unsubstantiated indications listed for selected antimicrobials in the Physicians' Desk Reference.
    Rybak MJ; Gleckman R
    Am J Hosp Pharm; 1979 Jun; 36(6):738. PubMed ID: 463882
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacy sources of drug information.
    Eckel FM
    Drug Inf J; 1979; 13(1):15-20. PubMed ID: 10242946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.